I don't think people appreciate the gravity and co
Post# of 148179
Have a good look at this chart and figure out why some of these parties may want a say in Leronlimab becoming the next Standard of Care. This, of course, is only a fraction of the interests that will be impacted. And don't forget, the supply of Leronlimab is pitifully small.
https://www.fda.gov/emergency-preparedness-an...a-issuance
The key word that concerns me as I look at this chart is "consultation". I am not at all surprised by the "cone of silence" that seems to have descended upon Cytodyn and those they are talking with about this EUA. This is HUGE! We should do our best to let that sink in!